Clinical trials
Cardiovascular clinical trials
Below are recruiting cardiovascular clinical trials, each written for real people, not researchers. We’re tracking 1,157 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06443151Recruiting
Blood Vessel Health After Spinal Cord Injury
This study looks at how blood vessel health is affected in people with long-term spinal cord injury (over 1 year). It tests whether blood vessel function plays a role in heart and circulatory risk.
Englewood, ColoradoAges 18–89 - NCT06560983Recruiting
Blood sugar and stroke outcomes over one year
This study watches how blood sugar levels affect recovery and risks over one year in people who come to the ER with a stroke. It aims to help doctors better manage blood sugar during emergency stroke care.
Kathmandu, BagmatiAges 18 years+ - NCT07769528Recruiting
Heart pump support for severe heart failure
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07774507Recruiting
Daily movement and artery health in rheumatoid arthritis
This study looks at how daily movement patterns (like sitting, standing, and walking) relate to the buildup of plaque in arteries (atherosclerosis) in people with rheumatoid arthritis. It aims to understand if certain activity levels can lower heart risks.
Presidente Prudente, São PauloAges 18–65 - NCT06290154Recruiting
Heart health after liver transplant study
This study looks at factors that affect heart health after a liver transplant. It may help doctors better predict and manage heart problems in people with end-stage liver disease who are getting a new liver.
Guangzhou, GuangdongAges 18 years+ - NCT06517537Recruiting
Modified aortic root enlargement for small aortic valves
This trial tests a modified surgical technique for replacing a narrowed aortic valve in people whose valve opening is unusually small. The goal is to help the new valve fit better and work well.
Beijing, Beijing MunicipalityAges 50–70 - NCT07766434Recruiting
Registry for heart artery blockage treatment
This study looks at real-world outcomes for people with narrowed heart arteries (coronary artery disease). It may include those treated with stents (PCI) or medicines. Doctors will use a special computer tool to measure the severity of blockages and track health over time.
Beijing, Beijing MunicipalityAges 18 years+ - NCT05610215Recruiting
Hybrid or catheter ablation for atrial fibrillation in hypertrophic heart
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
BeijingAges 18 years+ - NCT06580977Recruiting
Exercise and memory in Parkinson's disease
This study tests whether a supervised exercise program can improve memory and thinking in people with Parkinson's disease. You may be able to join if you are between 50 and 80, have mild to moderate Parkinson's, and can walk independently.
Heidelberg, Baden-WurttembergAges 50–80 - NCT07763340Recruiting
Photon-counting ct heart scan for people with coronary stents
This study tests a new type of CT scan that takes very detailed pictures of the heart and stents. It may help doctors see whether stents remain open and guide future care.
Beijing, Beijing MunicipalityAges 18–100 - NCT07759635Recruiting
Effects of Plan B on heart health in young women
This study looks at how the emergency contraceptive Plan B (levonorgestrel) affects heart and blood vessel health in young, naturally cycling women. Participants will take the medication and have their cardiovascular health measured over a short period.
Hamilton, OntarioAges 18–35 - NCT06108414RecruitingPhase 4
Low-dose vs standard-dose blood thinner for older adults with atrial fibrillation
This trial tests whether a lower dose of the blood thinner rivaroxaban works as well as the standard dose for people 70 and older with atrial fibrillation (an irregular heartbeat). The goal is to find the safest dose to prevent strokes while reducing bleeding risks.
Beijing, Beijing MunicipalityAges 70 years+ - NCT07753174Recruiting
Omega-3 supplement study for healthy adults
This study tests a supplement containing omega-3 fats to see how it affects levels of DHA and EPA in your blood. If you're a healthy adult, you might join to help learn if this supplement can boost these important fats.
Las Vegas, NevadaAges 18–65 - NCT07754318Recruiting
EndoAnchor treatment for abdominal aortic aneurysm
This trial tests a device called EndoAnchor, which is used during surgery to help secure a stent graft in place for people with an abdominal aortic aneurysm. It aims to improve the seal and reduce complications, potentially helping people whose aneurysm shape makes standard treatment riskier.
BeijingAges 18 years+ - NCT06595134Recruiting
AI heart scan study for people with obesity
This study is testing an AI tool to improve heart scans in people with obesity who may have hidden heart disease. If you are 45 or older, have a BMI of 30 or higher, and your doctor thinks you might have heart problems, this study could help find them earlier.
ViennaAges 45 years+ - NCT06586203Recruiting
Genomic test to guide diabetes heart and kidney care
This study is testing whether a special blood test (genomic predictor) can help doctors better manage heart and kidney risks in people with type 2 diabetes. You may benefit from learning your personal risk score and getting more tailored care.
Montreal, QuebecAges 18 years+ - NCT06587971Recruiting
Intensive gum treatment for aortic stenosis
This trial tests whether intensive gum disease treatment can improve health in people with aortic stenosis (a narrowed heart valve). If you have both gum disease and mild-to-moderate aortic stenosis, you may be able to join.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07749417Recruiting
Detecting kidney injury early after heart procedures
This study tests a new light-based method to check kidney function right after heart surgery or imaging tests that use contrast dye. It aims to catch kidney damage early, so doctors can treat it sooner.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07742917Recruiting
Personalized lifestyle program for weight management
This program tests a personalized lifestyle plan designed to help you manage your weight and improve your health. It uses your genetic information and other personal data to tailor the support you receive.
Abu DhabiAges 25–50 - NCT07745491Recruiting
AI tool to predict pneumonia after heart surgery
This study uses artificial intelligence to help predict if patients might develop pneumonia after heart or blood vessel surgery. It aims to find warning signs early so doctors can act sooner.
TomskAges 18 years+ - NCT05769868RecruitingPhase 3
Esmolol test to spot heart problems in diabetes, cirrhosis, and cancer
This trial tests whether esmolol (a short-acting heart medicine) can help doctors identify certain heart-related problems in people with type 2 diabetes, liver scarring (cirrhosis), or specific cancers. It’s mainly about improving how heart issues are detected during ultrasound testing.
Barcelona, BarcelonaAges 18 years+ - NCT07736872Recruiting
Sleep apnea screening in diverse groups
This study is screening people from different backgrounds for obstructive sleep apnea (a condition where breathing stops and starts during sleep). It uses a sleep test and questionnaires to see if you might have it.
Guangzhou, GuangdongAges 18–80 - NCT07736222Recruiting
Does chewing affect artery stiffness in healthy adults?
This study looks at how your oral health and chewing habits might relate to your artery stiffness—a measure of heart health. Researchers will test participants' chewing ability and check their arteries using simple, non-invasive methods.
Innsbruck, TyrolAges 18 years+ - NCT05679024RecruitingPhase 3
Apixaban to prevent stroke in atrial fibrillation and kidney failure
This trial tests apixaban (a blood thinner) to prevent stroke in people with atrial fibrillation or atrial flutter who have very poor kidney function or are on dialysis. If you qualify, you may help researchers find a safer way to lower stroke risk for this higher-risk group.
HelsinkiAges 18 years+
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular?
- Yes. Clin2 currently lists 1,157 recruiting cardiovascular studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.